Physician profile

Robert Wg Gordon

Diagnostic Radiology · Hartford, CT

NPI 1619298387

$1,487.47

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$549.36

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Inari Medical, INC. $402.25 2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Boston Scientific Corporation $288.71 2022
Stryker Corporation $163.18 2022
Argon Medical Devices, INC. $161.91 2022-2024 Clot Management
Penumbra, INC. $134.11 2022
Biocompatibles, INC. $125.00 2019
Ethicon US, LLC $94.16 2019
Medtronic USA, INC. $80.83 2019
Cordis US Corp. $18.73 2022
Terumo Medical Corporation $18.59 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Robert Wg Gordon

$1,487.47

in general payments reported 2019-2025

Years
2019-2024
Top company
Inari Medical, INC.

https://glasscript.com/doctor/1234608/robert-wg-gordon

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.